A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2006
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006	CN1289466C Pharmaceutical compounds
12/13/2006	CN1289128C A pharmaceutical composition for treating headache disease, preparation process and uses thereof
12/13/2006	CN1289108C Chinese medicine preparation for treating senile dementia and preparation thereof
12/13/2006	CN1289099C Process for preparation of Rhus verniciflus extract and anti-cancer composition containing same
12/13/2006	CN1289090C Highly selective norepinephrine reuptake inhibitors and use thereof in medicament preparation
12/13/2006	CN1289083C 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
12/13/2006	CN1289079C Use of an cactus extract and compounds isolated therefrom for protecting nerve cells
12/13/2006	CN1289074C Method for preparing sodium ferulate sterilized raw-material medicine
12/13/2006	CN1289069C Pharmaceutical composition comprising a 5HT1 receptor agonist
12/12/2006	US7148378 Analgesics; neuropathic pain; bipolar disorders
12/12/2006	US7148352 Method of inhibiting neurotrophin-receptor binding
12/12/2006	US7148331 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
12/12/2006	US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006	US7148240 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148238 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]piperidine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder.
12/12/2006	US7148235 Heterocyclic amines such as 3-[2-(4-(1H-indol-3-yl)-3,6-dihydro-1(2H)-pyridinyl)ethyl]-6-7-dimethoxy-4(3H)-quinazolinone, used as antidepressants or anxiolytic agents for prophylaxis of psychological disorders
12/12/2006	US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
12/12/2006	US7148222 Substituted pyrido-pyridazine derivatives which enhance cognition via the GABA-A receptors
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006	US7148208 For therapy and prophylaxis
12/12/2006	US7148206 Methods and compositions for treating flaviviruses and pestiviruses
12/12/2006	US7148012 Therapeutic agent for fibromyalgia
12/12/2006	US7148001 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
12/12/2006	US7147877 Method for treating lesions caused by estrogen deficiency with extract of cucumber
12/12/2006	US7147876 comprises Aloe vera, Vitamins, mineral concentrate, organic oils concentrate, Chinese herb, essential oil and spice; for medicinal/cosmetic use
12/12/2006	CA2451725C Therapeutic combinations for the treatment of hormone deficiencies
12/12/2006	CA2268314C Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems
12/12/2006	CA2257931C Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
12/12/2006	CA2215680C Prilocaine and hydrofluorocarbon aerosol preparations
12/12/2006	CA2190851C Palladium catalyzed ring closure of triazolyl tryptamine
12/12/2006	CA2154161C Therapeutic uses and delivery systems of dehydroepiandrosterone
12/12/2006	CA2153570C Pharmaceutical composition for treating nicotine dependence
12/12/2006	CA2098176C Angiotensin ii receptor blocking compositions
12/07/2006	WO2006130676A2 Inhibition of neuronal damage
12/07/2006	WO2006130080A2 Quinoline derivatives as nk3 anatgonists
12/07/2006	WO2006130075A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/07/2006	WO2006129826A1 Novel piperidine derivative
12/07/2006	WO2006129788A1 Agent for regeneration and/or protection of nerves
12/07/2006	WO2006129785A1 Concomitant pharmaceutical agents and use thereof
12/07/2006	WO2006129784A1 INTERFERON-α REGULATOR
12/07/2006	WO2006129679A1 Spiropiperidine compound and medicinal use thereof
12/07/2006	WO2006129658A1 Vaccine and immunization method
12/07/2006	WO2006129623A1 Thienotriazolodiazepine compound and a medicinal use thereof
12/07/2006	WO2006129609A1 2-naphthylimino-5,5-disubstituted-1,3-thiazin derivative
12/07/2006	WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006	WO2006129583A1 Pyrazolone derivative
12/07/2006	WO2006129524A1 Carbonyl compound remover
12/07/2006	WO2006129318A2 Benzofuran derivatives with therapeutic activities
12/07/2006	WO2006129199A1 Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
12/07/2006	WO2006129190A1 Process for the preparation of almotriptan
12/07/2006	WO2006128735A1 Anti-inflammatory preparations and their intrathecal use in the therapy of inflammatory diseases of the central nervous system
12/07/2006	WO2006128462A1 Sertindole titration
12/07/2006	WO2006128337A1 A pharmaceutical composition for prevention and treatment of menopausal syndrome and method of preparing the same
12/07/2006	WO2006103342A3 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/07/2006	WO2006100082A3 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof
12/07/2006	WO2006100081A3 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/07/2006	WO2006094934A8 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
12/07/2006	WO2006092326A3 Mimetic peptides and the use thereof in the form of 20s, 26s and immunoproteasome inhibitors
12/07/2006	WO2006090289A3 Compounds for reducing aggregation of amyloid beta-peptide
12/07/2006	WO2006086978A3 Use of deuterated n-[2-(5-methoxy-1h-indol-3-yl)-ethyl]acetamides and the pharmaceutically acceptable salts thereof, and medicaments containing said compounds
12/07/2006	WO2006068954A3 PYRAZOLO[1,5-A]PYRIMIDINE ADENOSINE A2a RECEPTOR ANTAGONISTS
12/07/2006	WO2004071435A3 Enhanced Bioavailability Using Laser Resonant Homogenization
12/07/2006	US20060276650 Pyrazole compounds
12/07/2006	US20060276645 Novel carboxylic acid derivatives, their preparation and use
12/07/2006	US20060276642 Compounds to treat Alzheimer's disease
12/07/2006	US20060276524 2-(2,5-Dioxoimidazolidin-4-yl)-N-[2-(4'-fluoro-biphenyl-4-yl)-ethyl]-acetamide; asthma, chronic obstructive pulmonary disease, arthritis, atherosclerosis, restenosis; potent and highly selective inhibitors
12/07/2006	US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006	US20060276509 Tripeptidyl peptidase inhibitors
12/07/2006	US20060276497 Novel multicyclic compounds and the use thereof
12/07/2006	US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
12/07/2006	US20060276485 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/07/2006	US20060276481 Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006	US20060276475 Triazolotriazines and pyrazolotriazines and methods of making and using the same
12/07/2006	US20060276474 Novel carboxylic acid derivatives, their preparation and use
12/07/2006	US20060276467 Sodium channel modulators
12/07/2006	US20060276462 Method of treating cognitive decline due to sleep deprivation and stress
12/07/2006	US20060276460 Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns
12/07/2006	US20060276452 Use of azetidinecarboxamide derivatives in therapy
12/07/2006	US20060276449 depression, anxiety, neurodegenerative disorders, eating disorders, hypertension, gastrointestinal/immunological diseases, drug dependence, epilepsy, cerebral infarction/ischemia/edema, head trauma, inflammation, alopecia; arginine-vasopressin V1b receptor antagonists; metabolic stability
12/07/2006	US20060276433 Hydrazone derivative
12/07/2006	US20060276427 Regulation of endogenous gene expression in cells using zinc finger proteins
12/07/2006	US20060276415 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
12/07/2006	US20060276397 Crystallization of IGF-1
12/07/2006	US20060276392 Treatments employing neuronal exocytosis-inhibiting peptides
12/07/2006	US20060276384 Peptides and medicinal compositions containing the same
12/07/2006	US20060275758 Use of pp2a phosphatase modulators in the treatment of mental disorders
12/07/2006	US20060275359 Palliative effects of morinda citrifolia oil and juice
12/07/2006	US20060275326 Administering a botulinum toxin
12/07/2006	US20060275325 Method for treating allodynia by peripheral administration of a neurotoxin
12/07/2006	US20060275298 Antagonist of Th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases
12/07/2006	US20060275297 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal
12/07/2006	US20060275290 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases
12/07/2006	US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination
12/07/2006	DE202005020881U1 Psychostimulans enthaltende pharmazeutische Zusammensetzung Psychostimulant containing pharmaceutical composition
12/07/2006	DE102005025625A1 New benzazecine derivatives are dopamine receptor antagonists useful to treat schizophrenia
12/07/2006	CA2611060A1 Quinoline derivatives as nk3 antagonists

1 ... 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 ... 1833